arrow
J

Javier Villanueva-Meyer

University of California San Francisco
H指数:48
被引数:8,165

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective consecutive genomic profiling defines the distribution of meningioma molecular alterations across demographic groups

前瞻性连续基因组分析定义了不同人口统计群体中脑膜瘤分子变异的分布

2026-08-190
PRE
Development and First-in-Human Translation of Hyperpolarized [1-13C]Alpha-Ketoglutarate MR Spectroscopy in the Brain

脑内高极化[1-13C]α-酮戊二酸磁共振波谱的开发与首次人体转化研究

Sensors
IF3.5
2026-04-290
OA
IMG-97. Advancing hyperpolarized13C MRI for non-invasive assessment of blood-brain barrier integrity and IDH mutation status in glioma

IMG-97. 推进高极化13C MRI技术,以用于非侵入性评估血脑屏障完整性和IDH突变状态在胶质瘤中的情况

2025-11-110
OA
IMG-117. Characterization of recurrent IDH-mutant glioma using multiparametric1H/Hyperpolarized-13C MRI and histopathological analysis

IMG-117. 利用多参数^1H/超极化^13C MRI和病理组织学分析对复发性IDH突变型胶质瘤进行表征

2025-11-110
OA
Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30

在神经肿瘤学会成立30周年之际,回顾科学增长与创新

2025-11-040
PRE
A coordinated care model for multidisciplinary meningioma treatment and research

多学科脑膜瘤治疗与研究的协同护理模型

2025-11-010
OAAI
Hyperenhancement of pituitary neuroendocrine tumors (PitNETs) on preoperative MRI: implications on tumor characteristics and outcomes

垂体神经内分泌肿瘤(PitNETs)术前MRI高强化:对肿瘤特征和预后的影响

2025-11-010
OAAI
A Vision Transformer-Based Approach to Predict Glioblastoma Recurrence from Metabolic and Diffusion MRI for Personalizing Radiation Planning

基于视觉Transformer的方法,用于从代谢和扩散MRI预测胶质母细胞瘤复发,以个性化放射治疗计划

2025-11-010
OAAI
Unveiling glioblastoma heterogeneity with deep learning derived MRI subtyping: insights from the global ReSPOND consortium

利用深度学习衍生MRI亚型对胶质母细胞瘤异质性进行解析:全球ReSPOND联盟的见解

2025-11-010
OAAI
Integrating AI-based models from physiologic MRI with MR spectra for differentiating treatment-effect from glioma tumor recurrence

整合基于生理MRI的AI模型与MR波谱,以区分治疗效应与胶质瘤肿瘤复发

2025-11-010
OAAI
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation

人工智能在儿科神经肿瘤学反应评估中的应用(AI-RAPNO),第二部分:临床转化中的挑战、机遇与建议

2025-10-270
PRE
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the art

人工智能在儿科神经肿瘤学反应评估中的应用(AI-RAPNO),第一部分:当前技术状态的综述

2025-10-270
PRE
Preoperative embolization improves local control and modulates gene expression in atypical WHO grade 2 meningioma

术前栓塞可改善世界卫生组织(WHO)二级非典型脑膜瘤的局部控制效果并调节其基因表达。

2025-09-010
PRE
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI

基于人工智能驱动的代谢和扩散MRI预测胶质母细胞瘤复发的创新放射治疗靶区定义

2025-08-070
OAAI
Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report

神经肿瘤学反应评估(RANO)2009–2025:广泛范围与实施——进展报告

2025-06-012
PRE
Multi-institutional atlas of brain metastases informs spatial modeling for precision imaging and personalized therapy

多机构脑转移瘤图谱为精准影像和个性化治疗的空间建模提供信息

2025-05-150
OA
Considerations on the Application of RANO 2.0 Criteria in Clinical Practice Reply
2024-12-270
PRE
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses
2024-11-190
OA